MRK241108P99000
- 0.54
- 0.000.00%
Merck & Co Newsroom
The election has officially kicked off! The ultimate choice for the President of the United States, these four contingency plans are here to "escort" you.
In 2024, the usa presidential election may have four main outcomes (victory of two candidates, with different combinations of congressional control), each of which could have different impacts on the global financial markets.
【Real-time Tracking】Trump vs. Harris, who will ultimately take over the White House?
On November 5th, USA will hold the 60th presidential election, the current vice president Harris and former president Trump will officially compete. Finance Associated Press will track and report the latest developments of this election, so please stay tuned.
Direct hit on the USA election: When is the earliest possible outcome of this election?
The earliest time the results of this year's usa election will be announced. Market volatility is likely to soar, traders need to do risk management.
Direct hit on the USA election | Trump VS Harris, who will win?
The 2024 US presidential election will officially vote on November 5, kicking off a critical battle that will determine the future direction of the United States.
Express News | Merck: It is expected to introduce more than 40 new products and new approvals to China in the next five years.
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
USA election, who will win? The two main candidates are battling in the 'swing states', this guide for watching and trading is worth collecting!
This may determine the direction of the US economy for the next four years. This may determine the direction of the US economy for the next four years.
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $120 to $125
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $136
Countdown to the USA election, when will the results be announced? Please keep this viewing guide handy!
"The big show" is about to begin, grab your "program."
Merck Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Adjusts Merck & Co.'s Price Target to $135 From $139
Merck & Co Analyst Ratings
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $110 to $150
Express News | Merck & Co., Inc. : Morgan Stanley Cuts Target Price to $123.00 From $130.00
Trending: Merck & Co. Lowers 2024 Adjusted EPS Outlook
Sector Update: Health Care Stocks Retreat Thursday Afternoon
Sector Update: Health Care